MF ac 2

NORSID CASE: Notorious Repeated Systemic Institutionalized Damages.

OPERATION MICROFLUITION: for preventive full mass non-symptomatic micro fluid testing, against anti/partial testing, post/anti symptomatic, adverse-drug-reaction/substance-abuse drug industries.

ACCUSATION: inclusion of accusation available for certified prosecutors and any citizen using email jusistem (at) jusistem.com; Notorious Repeated Systemic Institutionalized Damages.

continuation of part 1:

The Pfizer x Theranos tech-war would be an easy win for Theranos, if Human health is the prime interest, not short term exploitation profiteering, because of 80% average efficiency bio-medicine versus real world under 20% chemo-medicine (30% clinical trial average efficacy), specially after collateral effects of drug industry, with their low efficacy/effectiveness and lethal side effects.
During the progressive Democrat Obama Administration Pfizer/Ian Read was under regulatory and judicial negative scrutiny while Theranos/Elizabeth Holmes had stellar growth and support. After 2016 Donald Trump elected, with support of Pfizer CEO then Chairman Ian Read, paying 1 million “donation” on inauguration and another million for a luncheon. This resulted in a new appointed FDA director, Scott Gottlieb, future Pfizer board member, critic of previous administration and Theranos in 2016 Forbes article. This article followed 2015 WSJ article published also Trump supporter WSJ controller Rupert Murdoch. The political situation flipped, even though the technical situation in terms of divergent/rival bio/chemical technologies, remained the same.
Pfizer's alleged 30% Lipitor clinical trial efficacy remained inferior to Theranos 70% efficient micro-fluid blood test. It was going to test Pfizer Lipitor real world efficiency, probably even lower than the producer contracted clinical trial, specially after medium/long term collateral effects, including FDA warned diabetes. Collateral effects for prescribed dosage and/or for overdosing, takes place when funds are directed to advertising instead of research. Pfizer is an organization that under CEO/Chairman accountant Ian Read, invested US$3 billion annual budget in marketing, stimulating consumer/patients to dose, overdose and consume drugs for long periods, without any sustainable improvement of the disease or of Life expectancy. Pfizer top selling drugs Lipitor, Zoloft and Viagra play with human psychology fragility in face of gluttony, depression and sexual frustration, plays with symptoms instead of causes.

Administration/Medical professionals concerned with patient health first would invest advertising funds in research and let doctors prescribe medications on its know merits, appointed by studies and referrals. Simple nutrition administration, reducing animal fat/cholesterol consumption generates better results than artificial suppression of production of Human cholesterol with multi-functionally. The Human body system has already a control of level of production, which may present problems when there is excess, psychological stimulated excess consumption. Drug Lipitor is just a copycat of other failed statin drugs, that were a distorted copy of a human process, artificially changed to generate a patent, to generate monopoly abuse, price gouging and psychological entrapment of patients trying to escape diets, better served by nutrition selection. Theranos micro-fluid testifying could easily prove Pfizer Lipitor and other drugs, Adverse Drug Reaction and/or placebo like effect.

On August 8, 2022, convicted Elizabeth Holmes' second Prosecutor, Jeff Schenke joined law firm Jones Day, who represented/represents the drug industry, big tobacco, big pharma, including Pfizer.
The drug industry is directly impacted by the development of mass micro fluid testing against substance abuse/overdose, adverse-drug-reaction and placebo-like psychological drugs.
First prosecutor Robert Leach was associated five years to law firm to Latham and Watkins, that also represented/represents big pharma, including Pfizer and participated in multi-billion Pfizer acquisition deals in 2023, as GBT, Global Blood Therapeutics, acquired/shut-down by Pfizer, as blood testing Theranos Elizabeth Holmes, target of three Pfizer “partnership”/acquisition failed attempts and successful trojan-horse investing-destruction by Pfizer advertiser, distributors and investors, was sent to jail, after trial using Pfizer employee as witnesses, solicited by prosecutors to tell jurors how their rival competitor was actually not a good investment and fooled investors. If this was a movie, viewers would think it was not realistic that such a biased, conflict-of-interest parties could participate in such a trial or why their should be a trial in the first place as no damage, other than done by the accusers was proven.

Pfizer's web site describes their “Political Partnership” policy: “Our public policy activities focus on helping to build a constructive discourse in the political and regulatory environment while supporting policies – and policymakers – who share in our purpose and position us to better deliver these same ideals.” Time lined facts show political quid-pro-quo exchange of advantages with politicians and regulators as between Pfizer Ian Read, FDA director Scott Gottlieb and President Donald Trump. Pfizer leadership abusive “business partnerships” against their competitors were abusive, anti-competitive, damaging and illlegal, like the one they offered to Theranos and other competitors as Ranbaxy, Moderna, AstraZeneca, BioNTech and Novavax etc. On the political side they follow the usual corporate trend of giving 2-4 dollars to conservative republicans for every 1 dollar to moderate Democrats to keep an image of fairness, specially when Democrats are in power or favorites in polls. In 2016, Pfizer leadership claimed they had funded polling favorite Hillary with 400k, while Trump with only 100k, post-election that was inverted with US$2M donation for inauguration and luncheon donations for Trump. Pfizer is a highly politically articulated “lobbying” organization, under CEO then Chairman accountant Ian Read. Quid pro quo, advantage for advantage proves that these contributions are bribes and that lobbying means corruption.

Pfizer Accountant/CEO/Chairman Ian Read doctor-disciples Scott Gottlieb, appointed to FDA director after his article on Forbes attacking Theranos/Obama FDA, then to become Pfizer Board member and his CEO 2020 successor doctor Albert Bourla, to lead Pfizer advancement into destroying the effectiveness of bio-medicine, dropping efficacy of vaccination from over 80% to under 40% in real world, for not vaccinating all pandemic/endemic population, while Ian Read continued as Chairman of Board. Pfizer obtained an emergency approval for a “new” old untested technology mRNA, available since 1980s, but without a single vaccine approved, allegedly patented vaccine for an exosome mRNA, renamed lipid-nano-particle, copied from Moderna, a failed acquisition attempt by Pfizer. Vaccine sold 10 to 20 times more expensive than proven inactive/fragment virus vaccines, tested technology with over 200 labs capable of producing at average US$0.84 cents a dose, according to World Health Organization, instead of the pre-sale US$10, then sale $20 dose of Pfizer, price-gouging costing billions more to “lobbied” governments. Theranos micro fluid testing could also test for pathogens, as their technology was used for Covid testing. Micro fluids can also test the real effectiveness of vaccines and anti-virus drugs, detecting antibodies/white cells versus virus in blood.

Inefficient health results, high efficacy short term profits, threatened by damage recouping lawsuits, and conflicted political/business/judicial track record. Pfizer is trying now to go bio-medical, copy-cating their failed acquisition but trojan-horse destroyed Theranos, seeking to acquire/partner with organizations/individuals that patent nature, as a natural mRna exosome, renamed “lipid nano-particle”, on their covid vaccine “partnership” with BioNtech, a copycat shell company to supposedly avoid direct litigation. This vaccine was copied from Moderna, a failed acquisition/partnership target, which in turn licensed patents granted to little-bios connected to Universities and Government Institutes and research financing. These can more easily get those wrongful patents, copied from nature or with unnecessary artificial changes to natural processes, as changing mRNA to supposedly fool the immune system to enter cell to then fool the cell into producing foreign protein and fool again the immune system to believe the cell is under attack and/or the protein is foreign. Pfizer, under this type of leadership is a threat to public health, national and global security including to Humanity as, Russian-roulette mutations arising from profitable endemic partial-vaccination, caused Covid and in the future other super-virus or super-bacteria may arise. Crucial to clear Pfizer from destructive leaderships and to release constructive leadership of Theranos, a positive awarded biomedical organization, Elizabeth Holmes from wrongful imprisonment and providing her with damages of US$10 billion and punitive damages of US$100 billion paid by leadership executives/shareholders of Pfizer, News/Fox corporation and US government specially Ian Read, Rupert Murdoch and Donald Trump, which share a common Scottish ancestry and Scott Gottlieb, economist-turned-doctor, also Republican, chosen probably because of an article on Forbes against Theranos/Obama FDA and with a curious coincidental probably sympathetic first name for them, to lead the FDA, away from Theranos and in favor of Pfizer, to then join Pfizer board of directors for a quid-pro-quo-pay-day.
The Pfizer mRNA vaccine claimed on Pfizer financed clinical trial to have 95% efficacy, turned into a probable 40% effectiveness/efficiency in real world, as the Flu vaccines, because of lack of 95% coverage, raising viral load and mutation in available hosts. This new technology vaccine was available since 1980s, but no vaccine was ever developed, probably because of the uncertainty results from confusing immune system with foreign species proteins produced in human cell. This technology should have never been granted emergency approval since their were other available tested technologies and over 200 labs ready to produce them at US$0.84 a dose vaccine average, according to the World Health Organization. Pfizer pre-sold their mRNA vaccine for US$10 a dose, than sold it for US$20 dose, when their main initial pitch to governments and public being that it was a lower cost technology to produce, but if true consumers/taxpayers saw none of it. Theranos tests were used to identity covid virus and could also test the real world effectiveness of vaccines.
Pfizer big pharma competitors as Merck/Bayer settled lawsuits in multi-billion cases and removed their drugs from market, following negative scientific studies. Pfizer leadership, coming from Ian Read, an accountant, ex-CFO, not a health scientist, decided to fight judicially and politically for Pfizer's two best selling drugs Zoloft/Lipitor, following evidence of their low effectiveness placebo like and collateral effects. Enterprises and their regulators have the obligation of following clinical trial efficacy tests with real world effectiveness/efficiency tests, so they cannot allege that third party effectiveness studies are flawed, not comprehensive, when it should be up to them and regulators to produce evidence that they are. Theranos micro-fluid test service and test machine were going to test drugs as Lipitor, with alleged low 30% clinical trial efficacy and probable under 20% real world efficiency, named explicitly as a target in 2015 mini-lab patent, for Adverse-Drug-Reaction, possible by low cost low invasive daily/weekly/monthly individual tests.
Pfizer-advertiser WSJ/NewsCorp/Rupert Murdoch struck back questioning Theranos/microfluid +70% general effectiveness, with malicious “faulty”, subjective, unfounded, speculative allegations. Blood is a dynamic fluid with input/output of substances and variation in space and time, variable readings are natural not faultiness of test, equipment and/or lab.

Pfizer Zoloft anti-depressant drug, placebo-like lawsuit was dismissed by judge Lucy Koh, later to be assigned the Elizabeth Holmes/Theranos case. She alleged statute of limitations expiration of time to sue, from alleged first time of purchase, but accepting scientific evidence but blocking class action for other timely cases. This expiration cannot apply to a health product given the complexity in determining causation and long term collateral effects. Pfizer Lipitor case was dismissed later in a class action, taken to the republican dominated small state of South Carolina, by judge Richard Gergel, because judge thought scientific evidence was not comprehensive/large enough. Larger studies demanded larger funding. These cases were shut down without considering scientific evidence available at theoretical, empirical and practical levels. It should be up to drug producer to prove effectiveness of their product in the real world, to confirm alleged empirical clinical trial financed by them, already low, or counter evidence with an alleged more comprehensive evidence of the effectiveness and of no collateral effects. Alleging collateral effects are only related to overdosing or over frequency use, disregards the context where the producer of the drugs Pfizer, spends US$3 billion advertising to consumers, instead of investing these funds in research and using a small budget to divulge positive results to the professional medical community. This generates responsibility of the advertiser for the harmful drug overdose, regardless of alleged warnings to psychologically vulnerable, addicted consumers.

Theranos was proposing micro-fluid testing Lipitor at points of sale with individual results, in 2015 mini lab patent emphasizing Adverse Drug Reaction tests as one of its primary uses. Pfizer-advertiser Wall Sreet Journal published in 2015 article claiming Theranos machine/lab/test were faulty. Machine mini lab is just a miniaturization and modularization of lab equipment. Micro-fluid testing has high 70% efficiency, where the 30% divergence is mainly due to natural dynamic substance variations of blood. Micro fluid real time, systematic, low cost testing can compare clinical trial efficacy paid for by the drug producer with real world effectiveness/efficiency and also test for collateral effects. This would lead to probable debacle of Pfizer and other big-pharma drugs, running already under low 20-40% efficacy alleged clinical trials, as 30% for Lipitor. Theranos had already received Pfizer "exploratory investment", then called unsatisfactory service fee, because Pfizer employee claimed in trial it was not met with expected “cooperation” from Theranos, that is Elizabeth Holmes did not want to sell out to a notorious aggressive acquirer of competitors. This was a dispute of over 80% efficient bio-medicine against inefficient under 20% pharma/chemo-medicine. Micro-fluid testing can surpass Macro-fluid efficiency if using multi-samples, as 3 from finger/toe/stomach in 3 time intervals, totaling 9-10 samples, eliminating average diverging samples, due to other variables of a varying composition blood study. This statistical procedure used by PHD Theranos employees, perfectly valid and in fact more precise was considered “fraudulent” by undergraduate intern whistle blower, working months at that job.

Theranos capacity, Intellectual property, could be objectively evaluated, instead of gossip speculated by a sensationalist article from a competitor advertiser, via USPO internet published 859 patents, FDA test approval/pipeline of approvals, sophisticated institutional due diligence investors, web site description of technology and long term use of micro fluid testing as a service/product. It is a technique widely used, available since 1980s, that can be directly performed, subcontracted and/or own product mini lab machine developed to perform real-time multi-tests in a compact format to be used in-house or sold to retailers, doctor offices, hospitals or directly to consumers/patients in more advanced future mass production versions. A technology directly threatening the short term profiteering chemo-based drug industry, because of low cost, frequent testing showing side effects, low effectiveness placebo-like results and substance abuse/overdose/over frequency of use, that would destroy easy price gouging profits.

Patent filed Sept 28, 2015 (Patent No: US 10,533,994 B2) for Theranos/Holmes miniLab, mentions Pfizer Lipitor as example of drug to test for ADR Adverse Drug Reaction, that could be detected by using real-time, continuous, low cost micro fluid testing, allowing to detect results (efficacy of clinic trial and effectiveness in real market), lack of results (result similar to a placebo) and collateral effect (negative side effects). Pfizer-advertiser/NewsCorp/WSJ/Rupert Murdoch, 2014-15 Theranos trojan-horse-investor, responded immediately on October 15, 2015 publishing an WSJ article by John Carreyou attacking Theranos micro-fluid test/machine/lab as “faulty” without any objective measurement of faultiness as compared to other similar bio-medicine tests or with the chemo-medicine drug industry, over 80% versus under 20% effectiveness. There was nothing wrong with Theranos or any of other micro-fluid-testing bio-medical testing before or after this article. Theranos was given the award of enterprise of the year by bio-medical association. Blood is a dynamic liquid with changing substance content with a by natural 20-30% variability to a 70-80% average testing.

At the time, Lipitor/Zoloft Pfizer top selling drugs were being accused, based on scientific data/reasoning in private/class action lawsuits of being placebo-like and having collateral side effects. Judge Lucy Koh, future Holmes/Theranos judge, admitted that Zoloft had a performance similar to a placebo, but declined any damages based on a statute of limitations interpretation, alleging that patient filed a complaint 7 months after alleged expiration date from date of first purchase and also denied formation of class lawsuit. This judge was the same that accepted the case of fraud by sophisticated due-diligence private investors against Theranos/Holmes. The case was then sent to a judge Edward Davila for sentencing, with a history of sentencing a woman for almost 10 years in prison for a chili sauce, filling an alleged fraudulent lawsuit against a corporation Wendy's (also later a take-over target of Arby's holding company). The damage alleged by the judge was actually caused by publicity created by the press and judicial agents blowing up the case. Pfizer/Lipitor case was sent as a class action to a small state (South Carolina) to the hands of a judge that had a brother CEO of a large corporation. This judge considered studies against Lipitor to be insufficient, when in fact it should be the obligation of the drug producer and regulator (FDA) to prove to the public that the alleged, already low empirical efficacy of clinical trials, carried into real world results with a measure of its effectiveness/efficiency. The capacity to do that in large scale was exactly the proposition of Theranos/Holmes micro fluid system as a service (in house/outsourced) or with a product machine (in house or outsourced). Theranos had the right as any company, as Apple for example, to produce/outsource stages of their product/service.

Patent filed in Sept 28 2015 (Patent No: US 10,533,994 B2) for Theranos/Elizabeth Holmes:
"Similarly, the current techniques and systems for monitoring ADRs (Adverse Drug Reactions) are also inadequate. ADRs are one of the leading causes of morbidity and mortality in health care. The Institute of Medicine reported in January 2000 that 44,000 to 98,000 deaths occurred due to medical errors, of which 7,000 deaths were due to ADRs. Other studies conducted on hospitalized patient populations have indicated an ever higher overall incidence of several ADRs. Several reasons contribute to the prevalence of ADRs . First, there are more combination therapies available to patients . Second , there is an increasing trend towards chronic use of drugs (statins such as LIPITOR and Cox-2 inhibitors such as Vioxx). Chronic use of drugs also increases the chance that changes in the patient's lifestyle, health status and use of other medications will occur."

Pfizer first attempted “partnership” with Theranos in 2009, probable a dissimulated acquisition down payment, calling it an "exploratory investment", probably expecting that if money is taken the future acquisition is green lighted. Because supposedly Theranos denied information, or rejected the acquisition, the investment was later called a "service fee" and Pfizer representatives said they weren't impressed with what they saw. An industry sector leader as Pfizer does not want to promote a challenger like Theranos, specially when they have conflicting rival technology paradigms as chemo-medicine versus bio-medicine and because they were at the most inefficient side, averaging under 20% versus over 80%. So they claimed to have seeing nothing impressive or were denied to see if there was anything to see, as an excuse for not giving objective analysis. But in fact all of Theranos Intellectual Property was public and disclosed via Patents published on the internet, web site product/service descriptions and the theoretical/empirical/practice in the bio-medicine industry for micro-fluid testing, available since the 1980s and with other bio medicine competitors. In 2013 and 2015 Pfizer made, according to emails divulged in trial, a second and third attempt for a "partnership", in the form of sharing the "Wellness Centers" Theranos managed to secure with its distribution partner Walgreens also a Pfizer distributor. In trial, Walgreens had its CEO claimed to be fooled by Theranos CEO Holmes about Pfizer's interest in the company, with a report using supposedly unauthorized Pfizer logo. Pfizer/Walgreens CEOs had ongoing supplier/distributor relationship and they could connect in seconds from the touch of their cell phones. In fact all major passive investors following Pfizer first attempted acquisition/partnership were Pfizer connected, three Pfizer distributors (Safeway, Walgreens, Wal Mart), a Pfizer Shareholder (Partner Management Fund) and a Pfizer-advertiser (News Corp/WSJ/Fox/Rupert Murdoch). They all turned out to be trojan-horse investors, that seek administration board control to remove CEO, approve anti-competitive acquisition or shut-down the company. They all turned against the CEO/Holmes and the company, mainly because Theranos micro-fluid technology threaten the drug/chemo/pharma industry.

Theranos mini-lab could potentially replace the pharmacy for the doctor's office and eventually to be owned by the patient to self-tests. Additional they could also sell potentially bio treatments as self applied vaccines to patients. Probably they were told that plan A was to remove the CEO to unblock Pfizer acquisition, but Pfizer/Ian Read plan A was probably to destroy not only Theranos, but to discredit the whole micro-fluid and bio-medicine industry to protect their cash-cow chemo-medicine drugs or buy them time to enter the bio-medicine industry in a more profitable manner. Example is partial-vaccination generating never ending host/mutation profitable endemics as proven by the Flu industry, supporting the also extremely profitable chemo-anti-symptomatic industry that attack the bodies first line of defense. Chemo/Drug/Pharma industry could be destroyed by bio-medicine Adverse-Drug-Reaction, placebo-like effect and/or drug overdosing micro-fluid tests, devastating big pharma/big pharmacy short-term monopoly abuse profiteering. Pfizer would later try to acquire AstraZeneca, blocked by regulators, than Moderna for its mRNA licensed vaccines, finally to land “partnership” with BioNtech, copying Moderna with a proxy shell company. Moderna would later sue Pfizer. Their disputed/alleged patents are as usual copies from nature with unnecessary inefficient/side effect artificial modifications to claim patent. But so called lipid-nano-particle is just a name re-brand of natural mRNA exosomes.

Pfizer advertiser News Corp Rupert Murdoch, acquired/controlled news brands as Wall Street Journal and Fox News, was also allegedly “fooled” into investing in Theranos in 2014-2015, the most promising/valued bio-tech start-up based on value of IP, sophisticated due-diligence investors and regulator patent/product approvals. Murdoch had previously acquired and destroyed (bought for 800M sold, destroyed and sold carcass for 50M) the most promising media start-up MySpace, a direct competitor to his own business. Then he invested, turned around and decided to run an article on WSJ, against his own 125 million investment in Theranos, while taking ad dollars from its rival competitor Pfizer. The journalist going by the name of John Carreyou had a track record of attack-destroy articles against NewsCorp/FoxCorp rival Vivendi Universal/CEO Messier and Medicare, alleging doctor corruption instead of pharma high prices as source of high health costs. News Corp was a Pfizer advertiser with examples of Pfizer ads on WSJ and Fox News, as Xeljanz XR on WSJ.com, Prevnar 13 and Chantix on FoxNews.com. Pfizer according to Nielsen data spent in advertising 3.3 billion U.S. dollars in 2015, which was the highest among all pharma companies that year and probably one of highest in all sectors.

Murdoch/News Corp 125M investment in Theranos is small compared to Pfizer ad budget. He ran an article (Oct 15 2015) to attack/remove the CEO Elizabeth Holmes or to destroy his investment, later recouped by judge trial Edward Davila that ordered Holmes to return that exact amount to Murdoch. Theranos directly mentioned Pfizer best selling drug Lipitor on its patent mini-lab request (Sept 28 2015), as example of how Adverse Drug Reaction could be stopped with micro fluid real-time repetitive history test analysis. The competitive conflict of interest between these parties is obvious and the intention to invest-destroy Theranos too by the actions taken. Murdoch claimed that Theranos/Holmes requested removal of article and that he refused out of his commitment for fair journalism, when he was/is known to practice a notorious partisan, gossip, sensationalist, entertainment-fake-news, advertiser-for-hire-journalism and take-no-prisoners acquire/destroy approach towards competitors, as Vivendi-Universal and My Space. He was taking money from chemo-medicine Pfizer which was in competition conflict with bio-medicine Theranos which was considered/projected to replace Pfizer as health sector leader and technology paradigm changer from under 20% efficient chemo-medicine to over 80% efficient bio-medicine. Less invasive micro-fluid blood testing and Theranos were being criticized for having a 65-70% efficiency versus a 80% efficiency for invasive macro-fluid blood test. But products/services were complementary, micro for per-sympthomatic/frequent testing while macro for symptomatic/annual testing. In addition micro could surpass macro with multi-sampling from different parts of body, types of fluid and time frequency, with average, eliminating diverging results, product of natural variations of fluid compositions, generating results equal of better than macro fluid tests +80% practical/real world results, four times better than chemo/pharma efficiency/effectiveness results in the under 20% range, compared with alleged average 30% efficacy in producer financed empirical/clinical trials.

Theranos bio preventive testing service/products would be probably followed by entry in preventive vaccination, which was the path then taken by Pfizer/Ian Read after Theranos shut down. Pfizer's employees testimony in Theranos CEO trial attests the level of animosity toward their competitor, level of bias of prosecutors that were associated to law firms previously and after working for Pfizer and also FDA director later to join Pfizer administration board. Subjective sensationalist, gossip, smearing article in Pfizer advertizer Wall Street Journal followed a legal competitive threat of Theranos to test Pfizer best selling product, retaliated with anti-competitive illegal acquisition/partnership attempts and false/defaming accusations. News Corp/Rupert Murdoch when acquiring WSJ had promised they would not interfere with journalists/editors, which in this case he did, because the article was from start a quid-pro-quo article from Pfizer and/or Pfizer advertiser, Theranos trojan-horse invested, NewsCorp in clear conflict of interest taking sides with Pfizer with its US$3 billion annual ad budget.

FDA approved Theranos test and was on track to approve many other tests until the 2015 article against Theranos was publicized. Pfizer and Pfizer advertiser News Corp/Fox/WSJ/Rupert Murdoch are notorious major partisan donors/influencers and there was a political change in 2016 that changes the presidency of the United States and the director of the FDA from one party to the other, from predominant support to bio-medicine versus support to chemo-medicine. Elizabeth Holmes was indicted on June 14, 2018. Scott Gottlieb (an economist turned doctor) wrote an article on Forbes, April 18 2016, attacking Holmes and supposed error of FDA to approve her device/test but not looking after the service she was also providing: “But a deeper question is whether her vocal support for stricter FDA oversight of laboratory testing was always a calculated part of a careful marketing plan. Or was it a symptom of innocence as she contemplated the path for transitioning her tools business into a services enterprise?” One year later he was running the FDA, 2 years later working at Pfizer. Scott Gottlieb mas named by President Donald Trump, same that gave a “Warp speed” contract to Pfizer for Covid vaccine in “partnership” with BioNTech to copy Moderna supossedly novel mRNA vaccine and also compete with AstraZeneca vaccine, two companies that Pfizer/Ian Read had attempted to partner/acquire. The cost of vaccines estimated by World Health organization at 84 cents a dose was sky rocketed by Pfizer to 10 then 20 dollars a dose, putting this product on the path to shatter Lipitor's record of best selling drug. An Asian epidemic, was turned to a global Pandemic, then an Endemic, for simple failure to follow basic tracking, isolation, testing then full vaccination processes. Anti-vaccination/partial-vaccination were fundamental to avoid erradication raising viral load/mutation and dropping vaccine efficacy in half as happened previoulsy with Flu vaccine.

Elizabeth Holmes was prosecuted by prosecutors previously/futurely working in law firms with Pfizer as client, by attorney general appointed by Donald Trump and NewsCorp/FoxCorp/Rupert Murdoch were major supporters of his campaign/government, advertisers of Pfizer that ran article against Theranos in WSJ, a company acquired by News Corp, running Pfizer ads. Scott Gottlieb, new FDA director appointed by Trump, was a doctor that clearly admitted that Theranos sought FDA objective approval, than made subjective gossip of supposed non-specified non-objectified problems, just general gray accusations, such that the device was approved, but the nanotainer, a simple small container was not, the service was not approved, than the service was outsourced. So when the enterprise does the service it is “faulty”, but when it outsources the service, it is fooling investors/consumers claiming it is done in their device/lab. Any enterprise, including Apple for example, in-sources or out-sources its products/services based on a series of factors, including demand, availability/stage of development of internal processes, products and services. Micro-fluid blood testing has a technological advantage of allowing multi-samples to be tested in multiple sources to produce an average that includes eliminating diverging sample results, given the natural variability of human fluids. There is no “faultiness” in that divergence, it is natural to the substance in testing.

Theranos/Holmes and mini-lab device patented, revised by USPTO and FDA, named Lipitor, Pfizer best selling drug as target for Adverse Drug Reaction microfluid testing, given +2000 lawsuits and removal/lawsuits on other similar statin drugs. They proposed an efficiency/effectiveness real world testing to compare with theoretical/empirical concept/data of clinical trials that were already low (30%). A time line of frequent individual collateral/no effect testing that could comprise revenues/proftis of Pfizer and all low efficacy chemo/pharma/drug industry.Pfizer Lipitor was a drug that had a class action lawsuit denied because proving tests were considered by judge not broad/precise enough, when burden of running effectiveness tests of a drug is of the producer and regulator. FDA director Scott Gottlieb serving 2017-2019, was director, when FDA flipped from supporting to attacking Theranos. He then joined Pfizer highly paid board 83 days after leaving the FDA.

The notion that Theranos/Holmes fooled/defrauded the high knowledge staff of institutions and sophisticated due-diligence investors is illogical/unfounded and the opportunity for them to contest was given and they initially correctly concluded that bio-medicine and microfluid testing was the correct path to overcome the inneficiency of chemo-medicine, except that the investors were trojan horses connected to Pfizer/chemo-medicine and that public institutions had a political change.
Subjective opinions/interpretations as technology is "faulty", Pfizer logo was used to fool Walgreen CEO, when this one was/had the mean to be aware of Pfizer's interest in Theranos on three occasions (2009/13/15), including interest in partnering with Theranos on Walgreens, Wellness Centers. Rupert Murdoch/News Corp CEO then Chairman was advertiser taking millions from Pfizer, while supposedly “foolishly” investing in a rival/competitor who named Pfizer's leading drug Lipitor as an example of drug to be targeted in Theranos Adverse Drug Reaction/placebo-like non-reaction micro fluid testing. This technology was actually available since 1980s and could have avoided millions of deaths from collateral/placebo effect of silver-bullet targeted chemical artificial treatments.

Biological systems, such as the Human body, require system-compatible multi-variable natural compatible treatments. Theranos IP was fully public from easily accessible patent google search PDFs of USPTO files and Theranos company web site with full disclosure of technology. Theranos and many other enterprises offer micro fluid services that may be outsourced or performed at in house lab or proprietary machine. The notion that the service depended on Theranos machine is false and the difference in precision between a micro fluid test and a macro fluid test is known and small 70% x 80% efficiency, which is double than the average efficiency of the pharma industry widely approved products by the FDA with 30% average efficacy and probable limited untested real world effectiveness, waiting for courts to be swamped by medium-long term collateral effects lawsuits. Biotech is on average four times more efficient than pharma/chimo-tech because the Human body is a biological system, which includes multi-chemical secondary reactions, not a binary simple chemical system, as is the premise of most chemical drugs.

Pfizer, under the leadership of ex-CFO, accountant, Ian Read, had a long track record of aggressive, anti-competitive dealings with its competitors as Ranbaxy (anti-competitive license settlement with alleged generic copier of alleged patents 1 year before patents would be due anyway), Moderna (try to acquire company than launched vaccine copycat attack using third party partnership with BioNtech), AstraZeneca (attempted acquisition, launch of rival vaccine, suspected of press smear campaign that their vaccine caused side effects, AZ responded dropping price ten fold of their vaccine), BioNTech (partnered with little-bio copied alleged licensed patents of Moderna, as a so called RNA lipid nano-particle, nothing more than a copy of natural occurring mRNA exosome), Novavax (rival protein tech that went into a never ending FDA turtle process, while Pfizer cruised in at warp speed) and Theranos with attempted partnerships and fall outs that ended with a company destroyed, but to be reconstructed as justice prevails in the long run.

Theranos was attacked and destroyed because it probably, based on current and projected valuation, would have overtaken Pfizer as most valuable health enterprise, in 10 years, with micro fluid testing, probably with also with vaccination and other preventive health products, shifting the highly expensive and low performance palliative chemo to a bio paradigm. Ultra low cost micro-fluid testing of non-symptomatic citizens prevents damaging medical conditions including substance abuse, non-vaccination, early disease detection and can dramatically reduce health costs. It leads to substantial revenue/profit reduction of the drug industry. Opposition to this innovation, culminated in the attack on Theranos by trojan-horse workers/investors/judicial agents (competing individuals with conflict of interest connected to drug industry, specifically to Pfizer) and wrongful jail sentence on Theranos CEO/founder Elizabeth Holmes. Micro fluid test service uses current technology, including dilution of sample, with a +70% accuracy in contrast with a +80% accuracy for macro fluid testing, recommended to symptomatic patients visiting a doctor or to positive micro fluid testing double check. Multi-sampling of microfluids of different types, body extraction regions and times of extraction can increase the accurancy/efficiency/effectiveness of micro-fluids passed the 80% mark, 4 times higher than chemo-products averaging 30% efficacy and under 20% probable effectiveness that could be tested with micro-fluids.

Non-symptomatic micro fluid testers usually do not seek macro fluid testing unless symptomatic, so the service is an add on health benefit. Theranos additional development compacting Edison mini-lab machine threaten to replace traditional lab services, selling them to pharmacies, but price drop could make them available to doctors, replacing pharmacies, further price drop could make them affordable to citizens, replacing doctors. Such an innovation prospect led to dramatic, damaging, criminal action to destroy the leading enterprise in the field. There was no damage caused other than to the accused entrepreneur and enterprise with viable, valuable service and product. Substance abuse is a suicidal-homicidal behavior and vaccination/pathogen testing, specially of contagious diseases, specially by air, is a mandatory public health decision.

Sophisticated-knowledgeable investors/workers/suppliers/buyers, using their own due diligence and expert consulting, pressure founder-entrepreneurs to commit to targets/goals for product development, revenues and profits, to transfer risk/responsibility, so that they can then claim in particular negative circumstances and under conflict of interests, that founder-entrepreneurs lied to them as justification to taking control, seize assets, replace management, bankrupt/shut-down company ("Boiler-pressure-crystal-ball-entrapment"). This was the case with micro-fluid Theranos/Elizabeth Holmes where Trojan-horse conflict-of-interest parties accuse founder of lying (fraud) about product development/revenue projections, when they had equal or better sources of information on the company. Pfizer attempted to “partner” 3 times with Theranos, all main Theranos investors are trojan-horses connected to Pfizer, Pfizer distributors, investors and advertiser, as WSJ/NewsCorp/Murdoch, publisher of attack article against Theranos on 15 october 2015, 17 days after Theranos files a patent for mini-lab (28 sept 2015) mentioning using it to test Lipitor for Adverse Drug Reaction, Pfizer best selling drug, with FDA warning on diabetes and +2000 lawsuits. Prosecutors worked previously or after the trial for law firms working for Pfizer. Judge taking case, buried case against Pfizer Zoloft. New FDA director had published article on Forbes 2016 against Theranos and current FDA/Obama, was appointed by Trump to FDA, later joining Pfizer board. Facts point to anti-competitive set-up of Pfizer/Ian Read against Theranos/Elizabeth Holmes with damage surpassing US$10 billion and punitive damage/projected value of Theranos surpassing US$100 billion. Micro fluid tests emerged in 80s, with biomedical applications, lower cost, accuracy similar to macro fluid test (70%x80%), potentially better if using multiple samples from different body parts to test continuously/individually for Adverse Drug Reaction, real world drug efficiency, substance abuse, drug overdose, placebo-like, collateral effects, lacking substance. The economic/health abuse drug industry is particularly against this technique because of the potential to scale and significantly reduce their revenues/profits.